Authors


Sabrina Serani

Latest:

Retifanlimab Lengthens Survival for Patients With Anal Cancer

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.


Claudia Calderon, NP

Latest:

Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer Treatment

Experts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.


Rina Lokaj

Latest:

Adding Nivolumab to Chemo Increases OS, PFS in Previously Untreated Advanced GI Cancers

Overall survival and progression-free survival improves with nivolumab plus chemotherapy compared with chemotherapy alone in the overall population and in patients with a PD-L1 CPS of 5 or greater.


Ilene Galinsky, BSN, MSN, ANP-C

Latest:

Galinsky Breaks Down Venetoclax Symptom Management in AML

Ilene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.


Kate Esselen, MD

Latest:

Normalize Conversations Between Patients and Providers on the Financial Costs of Cancer

Nearly half of patients with gynecologic cancer reported financial distress as a result of the high costs of cancer treatment, yet money is still not commonly discussed between patients and providers.


Brenda Martone MSN, ANP-BC, AOCNP

Latest:

Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate Cancer

Brenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.


Jeanelle S. King, PA-C

Latest:

Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)

Jeanelle S. King, PA-C, provides an in-depth look at nivolumab-relatlimab in a downloadable reference sheet.


Gretchen A. McNally, PhD, ANP-BC, AOCNP

Latest:

Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid Epidemic

Gretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.


Don Vaughan

Latest:

Finding the Small Wins

The winner of the 2024 Extraordinary Healer® award, Meaghan Mooney, BSN, RN, OCN, found a rewarding career caring for patients and their families, even after transitioning to a leadership role. Now, she uses her expertise to help children facing a parent's cancer diagnosis.


Srigowri Kota, MSN, BA, RN, APN, AGNP-C, OCN

Latest:

Rx Road Map: Enfortumab Vedotin (Padcev)

Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.


Harrison Widelitz

Latest:

Anthracyclines Boost Survival, Increases Hospital Time in AML

Older adults with acute myeloid leukemia treated with anthracyclines tended to live longer, but also had more time spent in the hospital compared with those treated with HMAs.


Amanda Brink, DNP, APRN, FNP-BC, AOCNP

Latest:

Opinion: Comprehensive Genomic Profiling Is Vital for Optimizing NSCLC Care

Oncology nurses can ensure patients with non–small cell lung cancer receive the optimal treatment quickly by understanding comprehensive genomic profiling.


Margaret Rabatin, DNP, FNP-BC

Latest:

Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated Chemotherapy

Veno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.


Caitlin Benda, MBA, MS, RD, CSO, LDN

Latest:

Patients With Cancer May Need Help Changing Their Eating Approaches

Caitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.


Jeneth Aquino, DNP, APRN, FNP-BC

Latest:

Recognition of the Advanced Practice Preceptor Role in Oncology

A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.


Nicole Feraco, MSN, RN, OCN

Latest:

Power of Palliative Care: How Oncology Nurses Can Increase Referrals

A nurse-driven palliative care referral intervention demonstrated preliminary success in increasing the number of patients who received this form of supportive care.


Ronald Bleday, MD

Latest:

Nurse-Peer Mentorship Can Help Prevent Opioid Addiction in Post-Op CRC

Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, says expert Ronald Bleday, MD.


Claudia Maldonado-Howell, RN, MSN, FNP, BS

Latest:

Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient Ambulation

Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.



Donna Thomas, BSN, RN, OCN

Latest:

Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)

After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.


Annie Austin, MSN, AGACNP, AOCNP

Latest:

Menstrual Suppression Is a Valuable Component of HSCT Care for Premenopausal Women

Menstrual suppression can improve outcomes and quality of life in premenopausal women undergoing hematopoietic stem cell transplant.


Alyssa Hall, FNP-BC, AOCNP

Latest:

Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)

After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.


Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP

Latest:

Difficulty of Genomic Testing Conversations Highlights Need for Education

Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP, discusses the role of oncology nurses in genomic testing.


Donna Catamero, ANP-BC, OCN, CCRC

Latest:

Insights on Evolving Treatment Strategies for Multiple Myeloma

The panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.


Janelle Hart

Latest:

Adjuvant Mitotane Misses RFS End Point in Adrenocortical Carcinoma

Adjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.



Megan Price, MSN, APRN, FNP-C

Latest:

Normalize the Clinical Trial Conversation

"Clinical trials are the vital bridge between research and a drug’s eventual availability to patients."


Megan Schollenberger, MSN, CRNP

Latest:

The Road Ahead: Future Directions in Metastatic Melanoma Treatment

Panelists discuss the importance of effective communication and multidisciplinary collaboration in managing immunotherapy toxicities and ensuring seamless patient care, while highlighting promising advances in melanoma treatment and the role of telehealth and community outreach in expanding access and improving outcomes.


Amanda McKaig, BSN, RN, OCN

Latest:

Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis

Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.


Catherine Wu, MD

Latest:

With Personalized Cancer Vaccines On the Horizon, What Is Nurses’ Role?

Nurses and APPs provide an essential link between physicians and patients when facilitating and monitoring outcomes with personalized cancer vaccines.